Microfluidics for detection of exosomes and microRNAs in cancer: state of the art
Seyed Mojtaba Mousavi,Seyed Mohammad Amin Mahdian,Mohammad Saeid Ebrahimi,Mohammad Taghizadieh,Massoud Vosough,Javid Sadri Nahand,Saereh Hosseindoost,Nasim Vousooghi,Hamid Akbari Javar,Bagher Larijani,Mahmoud Reza Hadjighassem,Neda Rahimian,Michael R. Hamblin,Hamed Mirzaei
DOI: https://doi.org/10.1016/j.omtn.2022.04.011
2022-04-01
Abstract:Exosomes are small extracellular vesicles with sizes ranging from 30 to 150 nanometers, containing proteins, lipids, mRNAs, microRNAs, and double-stranded DNA derived from the cells of origin. Exosomes can be taken up by target cells, acting as a means of cell-to-cell communication. The discovery of these vesicles in body fluids and their participation in cell communication has led to major breakthroughs in diagnosis, prognosis and treatment of several conditions (e.g., cancer). However, the conventional isolation and evaluation of exosomes, and their microRNA contents, suffers from high costs, lengthy process, difficult standardization, low purity, and poor yield. In this regard, the emergence of microfluidic devices, which show increased efficiency in sieving, trapping, and immunological separation of small volumes, could provide improved detection and monitoring of exosomes involved in cancer. Microfluidic techniques hold promise for further advances in the development of diagnostic and prognostic devices. This review covers ongoing research on microfluidic devices for the detection of microRNAs and exosomes as biomarkers, and looks forward to their translation to point-of-care and clinical applications.